ArticleInternational journal of molecular medicine2013

Pretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarct.

Mónika Szepes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.